Page last updated: 2024-08-23

bromocriptine and oxidopamine

bromocriptine has been researched along with oxidopamine in 49 studies

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-199019 (38.78)18.7374
1990's15 (30.61)18.2507
2000's11 (22.45)29.6817
2010's4 (8.16)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silverman, PB2
Henke, PG; Ray, A1
Mandel, RJ; Randall, PK1
Kuramoto, S; Ohtsuru, K; Torigoe, R; Yoshida, M1
Campastro, OJ; D'Anna, L; Fernández, RA; González, SA; Loidl, CF; Pecci-Saavedra, J; Soqueff, MN1
Carruba, MO; Memo, M; Missale, C; Picotti, GB; Pizzi, M; Spano, PF1
Boyce, S; Jenner, P; Marsden, CD1
George, SR; Haas, DA1
Walters, JR; Weick, BG1
Jaton, AL; Karlsson, G; Vigouret, JM1
Bédard, P; Di Paolo, T; Falardeau, P; Rouillard, C1
Baden, DR; Kenny, AM; Murrin, LC; Pfeiffer, RF; Schneider, MB1
Fahn, S; Hassan, MN; Higgins, D; Traub, M1
Crowley, WR; Grosvenor, CE; Kacsoh, B; Shyr, SW1
Martínez, JA; Milanés, MV; Vargas, ML1
Fahn, S; Hassan, M; Jackson-Lewis, V; Traub, M; Wagner, HR1
Duvoisin, RC; Heikkila, RE; Manzino, L1
Carey, RJ1
Bagli, J; Bogri, T; Voith, K1
Deupree, JD; Murrin, LC; Pfeiffer, RF; Schneider, MB1
Armstrong, D; Courtney, CL; Palfai, T1
Draganova, S; Georgiev, V; Getova, D; Lazarova, M; Markovska, V; Petkov, V; Petkova, B; Roussinov, K; Shopova, S1
Anderson, GM; Batter, DK; Cohen, DJ; Lipton, SV; Shaywitz, BA; Teicher, MH; Young, JG1
Asanuma, M; Kawai, M; Kohno, M; Masumizu, T; Mori, A; Ogawa, N; Tanaka, K1
Bankiewicz, KS; Belluzzi, JD; Domino, EF; May, JM; McAfee, DA1
Dollison, A; Espinosa, A; Ferreira, M; Jackson-Lewis, V; Jiang, H; Muthane, U; Parsons, B; Przedborski, S1
Clemens, JA; Okimura, T; Smalstig, EB1
Abercrombie, ED; DeBoer, P; Heeringa, M; Westerink, BH1
Brotchie, JM; Crossman, AR; Henry, B2
Hironaka, N; Kohno, Y; Yanagita, T1
Cumps, J; Geurts, M; Hermans, E; Maloteaux, JM1
Barbanoj, M; Casas, M; Jané, F; Kulisevsky, J; Prat, G; Robledo, P1
Geurts, M; Maloteaux, JM; Noël, F1
Fukuzaki, K; Kamenosono, T; Nagata, R1
Barbanoj, M; Casas, M; Jané, F; Prat, G; Robledo, P; Rubio, A1
Brannan, T; Prikhojan, A; Yahr, MD1
Andersson, M; Cenci, MA; Lundblad, M; Westin, JE1
Andersson, M; Cenci, MA; Kirik, D; Lundblad, M; Wierup, N; Winkler, C1
Atsumi, M; Iga, T; Kawakami, J; Kotaki, H; Sato, H; Sawada, Y; Sugiyama, E; Yamada, Y1
Cenci, MA; Lindgren, HS; Lundblad, M; Ohlin, KE; Rylander, D1
Marvanova, M; Nichols, CD1
Cortesi, R; Drechsler, M; Esposito, E; Fantin, M; Lain, F; Mariani, P; Marti, M; Menegatti, E; Morari, M; Paccamiccio, L; Sivieri, E1
Cenci, MA; Lindgren, HS; Ohlin, KE1
Dunnett, SB; Lane, EL1
Asakawa, T; Ito-Yamashita, T; Namba, H; Sugiyama, K; Sun, W1
Dunnett, SB; Lane, EL; Lelos, MJ; Murphy, EM; O'Neill, MJ1
Chassain, C; Durif, F; Hafidi, A; Ouachikh, O; Pagès, G1

Reviews

1 review(s) available for bromocriptine and oxidopamine

ArticleYear
Receptor changes during chronic dopaminergic stimulation.
    Journal of neural transmission. Supplementum, 1988, Volume: 27

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome

1988

Other Studies

48 other study(ies) available for bromocriptine and oxidopamine

ArticleYear
Sensitization, response fluctuation and long-term effect of SKF-82958 and bromocriptine in the hemi-parkinsonian rat.
    European journal of pharmacology, 1992, Dec-15, Volume: 229, Issue:2-3

    Topics: Animals; Benzazepines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra

1992
The basolateral amygdala, dopamine and gastric stress ulcer formation in rats.
    Brain research, 1991, Sep-06, Volume: 558, Issue:2

    Topics: Amygdala; Animals; Bromocriptine; Cold Temperature; Dopamine; Dopamine Agents; Dopamine Antagonists; Haloperidol; Male; Microinjections; Neurons; Oxidopamine; Rats; Rats, Inbred Strains; Restraint, Physical; Stereotaxic Techniques; Stomach Ulcer; Stress, Psychological

1991
Bromocriptine-induced rotation: characterization using a striatal efferent lesion in the mouse.
    Brain research bulletin, 1990, Volume: 24, Issue:2

    Topics: Animals; Bromocriptine; Corpus Striatum; Hydroxydopamines; Male; Mice; Mice, Inbred C57BL; Oxidopamine; Stereotyped Behavior

1990
Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain.
    Stereotactic and functional neurosurgery, 1990, Volume: 54-55

    Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Corpus Striatum; Dominance, Cerebral; Drug Implants; Hydroxydopamines; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra; Thyrotropin-Releasing Hormone

1990
A novel, fully automated rotometer for the study of turning behavior. Comparison of results under different experimental conditions.
    Acta physiologica et pharmacologica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y de la Asociacion Latinoamericana de Farmacologia, 1989, Volume: 39, Issue:3

    Topics: Animals; Apomorphine; Bromocriptine; Dopamine Agents; Female; Hydroxydopamines; Kainic Acid; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra

1989
Postsynaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries.
    Neuroscience letters, 1985, Oct-24, Volume: 61, Issue:1-2

    Topics: Adenylyl Cyclases; Animals; Benzazepines; Bromocriptine; Fenoldopam; Haloperidol; Hydroxydopamines; Mesenteric Arteries; Oxidopamine; Rabbits; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Renal Artery; Sulpiride

1985
Effect of dopaminergic and alpha-adrenergic modulation on corticotropin-releasing factor immunoreactivity in rat hypothalamus.
    Canadian journal of physiology and pharmacology, 1988, Volume: 66, Issue:6

    Topics: Adrenergic alpha-Agonists; Animals; Bromocriptine; Clonidine; Corticotropin-Releasing Hormone; Dopamine Agents; Epinephrine; Haloperidol; Hydroxydopamines; Hypothalamus; Male; Methoxamine; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Reserpine

1988
D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway.
    Neuropharmacology, 1987, Volume: 26, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Bromocriptine; Corpus Striatum; Drug Synergism; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Substantia Nigra

1987
Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
    Neuroscience letters, 1988, May-16, Volume: 88, Issue:1

    Topics: Animals; Benzazepines; Bromocriptine; Hydroxydopamines; Indoles; Male; Motor Activity; Oxidopamine; Phenanthridines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra; Sulpiride

1988
Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
    European journal of pharmacology, 1988, Nov-22, Volume: 157, Issue:2-3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Appetite Depressants; Benzazepines; Bromocriptine; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Hydroxydopamines; Locomotion; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra

1988
Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
    Neurology, 1986, Volume: 36, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Binding Sites; Bromocriptine; Dopamine; Drug Administration Schedule; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra; Time Factors

1986
Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
    Life sciences, 1986, Aug-11, Volume: 39, Issue:6

    Topics: Animals; Apomorphine; Bromocriptine; Dopamine Antagonists; Humans; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior

1986
Evidence for stimulatory noradrenergic and inhibitory dopaminergic regulation of oxytocin release in the lactating rat.
    Endocrinology, 1987, Volume: 121, Issue:1

    Topics: Animals; Bromocriptine; Domperidone; Dopamine; Female; Hydroxydopamines; Hypothalamus; Kinetics; Lactation; Median Eminence; Norepinephrine; Oxidopamine; Oxytocin; Paraventricular Hypothalamic Nucleus; Pituitary Gland; Pregnancy; Rats; Supraoptic Nucleus

1987
[Interaction of opioid peptides and the dopaminergic system in the myenteric plexus of the guniea pig ileum].
    Revista espanola de fisiologia, 1987, Volume: 43, Issue:2

    Topics: Animals; Apomorphine; Bromocriptine; Drug Interactions; Endorphins; Guinea Pigs; Haloperidol; Hydroxydopamines; Ileum; In Vitro Techniques; Myenteric Plexus; Naloxone; Oxidopamine; Receptors, Dopamine

1987
The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
    European journal of pharmacology, 1985, Nov-26, Volume: 118, Issue:1-2

    Topics: Animals; Apomorphine; Bromocriptine; Corpus Striatum; Hydroxydopamines; Kainic Acid; Male; Motor Activity; Muscle Denervation; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra

1985
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
    Neurology, 1982, Volume: 32, Issue:12

    Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxidopamine; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains

1982
Bromocriptine promotes recovery of self-stimulation in 6-hydroxydopamine-lesioned rats.
    Pharmacology, biochemistry, and behavior, 1983, Volume: 18, Issue:2

    Topics: Animals; Bromocriptine; Dextroamphetamine; Dopamine; Electrodes, Implanted; Hydroxydopamines; Motor Activity; Norepinephrine; Oxidopamine; Rats; Scopolamine; Self Stimulation

1983
Troponoids. 6. Troponylpiperazines: a new class of dopamine agonists.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:7

    Topics: Animals; Bromocriptine; Cycloheptanes; Disease Models, Animal; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Structure-Activity Relationship; Tropolone

1984
Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Clinical neuropharmacology, 1984, Volume: 7, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Hydroxydopamines; Kinetics; Levodopa; Male; Membranes; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra

1984
Effect of l-dopa or bromocriptine on feeding and motor behavior of rats with lesions in the globus pallidus.
    Physiology & behavior, 1984, Volume: 33, Issue:2

    Topics: Animals; Body Weight; Brain Mapping; Bromocriptine; Carbidopa; Drinking; Eating; Globus Pallidus; Hydroxydopamines; Levodopa; Male; Motor Activity; Neural Pathways; Oxidopamine; Rats; Receptors, Dopamine; Sex Factors

1984
On some central effects of elymoclavine.
    Acta physiologica et pharmacologica Bulgarica, 1984, Volume: 10, Issue:4

    Topics: Animals; Bromocriptine; Catalepsy; Central Nervous System; Corpus Striatum; Ergolines; Exploratory Behavior; Haloperidol; Humans; Hydroxydopamines; Mice; Oxidopamine; Pimozide; Rats; Receptors, Dopamine; Seizures; Stereotyped Behavior; Sympathetic Nervous System

1984
Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Pharmacology, biochemistry, and behavior, 1981, Volume: 15, Issue:3

    Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Dopamine; Escape Reaction; Exploratory Behavior; Female; Humans; Hydroxydopamines; Male; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Stereotyped Behavior

1981
Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro.
    Brain research, 1994, Sep-19, Volume: 657, Issue:1-2

    Topics: Animals; Bromocriptine; Carbidopa; Corpus Striatum; Desipramine; Dopamine; Free Radical Scavengers; Hydroxyl Radical; Injections, Intraventricular; Levodopa; Male; Mice; Mice, Inbred ICR; Oxidopamine

1994
On-off effects of dopamine receptor agonists in the hemi-parkinsonian rat.
    European journal of pharmacology, 1993, Sep-21, Volume: 242, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cocaine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley

1993
N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Bromocriptine; Disease Models, Animal; Dominance, Cerebral; Dopamine Agents; Female; Injections, Intramuscular; Macaca nemestrina; Male; Oxazines; Oxidopamine; Parkinson Disease, Secondary; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior; Substantia Nigra; Tetrahydronaphthalenes; Thiophenes

1994
Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats.
    Brain research, 1993, Jun-11, Volume: 613, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Male; Motor Activity; Oxidopamine; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Theobromine; Theophylline; Time Factors; Xanthines

1993
Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior.
    Arzneimittel-Forschung, 1993, Volume: 43, Issue:3

    Topics: Administration, Oral; Animals; Bromocriptine; Corpus Striatum; Injections, Intraperitoneal; Male; Oxidopamine; Pergolide; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reserpine; Stereotyped Behavior; Substantia Nigra

1993
Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats.
    Brain research, 1993, Apr-16, Volume: 608, Issue:2

    Topics: Acetylcholine; Animals; Bromocriptine; Corpus Striatum; Dialysis; Levodopa; Male; Oxidopamine; Rats; Rats, Wistar

1993
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Experimental neurology, 1998, Volume: 151, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine

1998
[Comparative studies on antiparkinsonian agents, talipexole and bromocriptine, evaluated by contralateral rotational behavior in unilaterally nigral-lesioned rats].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1998, Volume: 112, Issue:4

    Topics: Administration, Oral; Animals; Antiparkinson Agents; Azepines; Behavior, Animal; Benzazepines; Bromocriptine; Dopamine Antagonists; Injections, Subcutaneous; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Substantia Nigra; Sulpiride

1998
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Experimental neurology, 1999, Volume: 155, Issue:2

    Topics: Animals; Autoradiography; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine Uptake Inhibitors; Enkephalins; In Situ Hybridization; Levodopa; Lisuride; Male; Mazindol; Medial Forebrain Bundle; Neostriatum; Oligonucleotide Probes; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Radioligand Assay; Rats; Rats, Sprague-Dawley; RNA, Messenger

1999
Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats.
    Brain research, 1999, Sep-11, Volume: 841, Issue:1-2

    Topics: Animals; Apomorphine; Benzazepines; Bromocriptine; Cell Membrane; Corpus Striatum; Domperidone; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Male; Oxidopamine; Piperazines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulfur Radioisotopes; Tritium

1999
Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:6

    Topics: Adrenergic Agents; Animals; Behavior, Animal; Bromocriptine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Drug Therapy, Combination; Drug Tolerance; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinson Disease; Rats

1999
Selective destruction of nigrostriatal dopaminergic neurons does not alter [3H]-ryanodine binding in rat striatum.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2000, Volume: 33, Issue:2

    Topics: Adrenergic Agents; Animals; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agonists; Male; Neuroleptic Malignant Syndrome; Neurons; Oxidopamine; Piperazines; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Substantia Nigra

2000
Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys.
    Pharmacology, biochemistry, and behavior, 2000, Volume: 65, Issue:3

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Catalepsy; Dopamine Agonists; Indoles; Macaca fascicularis; Male; Mice; Oxidopamine; Parkinsonian Disorders; Rats; Reserpine; Tremor

2000
Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats.
    Brain research, 2000, Jun-23, Volume: 868, Issue:2

    Topics: Animals; Bromocriptine; Caffeine; Denervation; Drug Administration Schedule; Drug Combinations; Drug Tolerance; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Rats; Rats, Sprague-Dawley; Rotation

2000
Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:10

    Topics: Animals; Benzothiazoles; Brain; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Indoles; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles

2000
Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease.
    The European journal of neuroscience, 2001, Volume: 14, Issue:7

    Topics: Animals; Bromocriptine; Denervation; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Drug Administration Schedule; Enkephalins; Female; Gene Expression Regulation; Immunohistochemistry; Levodopa; Neostriatum; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympatholytics

2001
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.
    The European journal of neuroscience, 2002, Volume: 15, Issue:1

    Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Dyskinesia, Drug-Induced; Female; Gait; Levodopa; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotation; Stereotyped Behavior; Sympatholytics

2002
Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats.
    Synapse (New York, N.Y.), 2003, Volume: 50, Issue:2

    Topics: Animals; Bromocriptine; Denervation; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Neostriatum; Neural Pathways; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D2; Rotation; Substantia Nigra

2003
The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.
    Behavioural brain research, 2007, Feb-12, Volume: 177, Issue:1

    Topics: Analysis of Variance; Animals; Brain Injuries; Bromocriptine; Cell Count; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Immunohistochemistry; Levodopa; Lipopolysaccharides; Movement Disorders; Oxidopamine; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Time Factors; Tyrosine 3-Monooxygenase

2007
Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.
    Journal of molecular neuroscience : MN, 2007, Volume: 31, Issue:2

    Topics: Animals; Bromocriptine; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cell Line; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Humans; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Quinpirole

2007
Solid lipid nanoparticles as delivery systems for bromocriptine.
    Pharmaceutical research, 2008, Volume: 25, Issue:7

    Topics: Absorptiometry, Photon; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Chromatography, High Pressure Liquid; Cryoelectron Microscopy; Dialysis; Drug Delivery Systems; Kinetics; Light; Lipids; Male; Microscopy, Electron; Nanoparticles; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Scattering, Radiation; Spectrophotometry, Ultraviolet; Triglycerides; X-Ray Diffraction

2008
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:12

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides

2009
Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat.
    Behavioural brain research, 2010, Nov-12, Volume: 213, Issue:1

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Oxidopamine; Parkinsonian Disorders; Piribedil; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotation; Time Factors

2010
Behavioral performance at early (4 weeks) and later (6 months) stages in rats with unilateral medial forebrain bundle and striatal 6-hydroxydopamine lesions.
    Neurologia medico-chirurgica, 2013, Volume: 53, Issue:1

    Topics: Adrenergic Agents; Animals; Behavior, Animal; Bromocriptine; Corpus Striatum; Injections; Male; Medial Forebrain Bundle; Methamphetamine; Motor Skills; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior

2013
Long-term restorative effects of bromocriptine on operant responding in the 6-hydroxydopamine-lesioned rat.
    Neuroreport, 2013, Dec-18, Volume: 24, Issue:18

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Conditioning, Operant; Dopamine Agonists; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Reaction Time

2013
mGlu5 receptor antagonist blocks bromocriptine-induced conditioned place preference in bilateral mesolimbic-lesioned rat.
    Behavioural brain research, 2017, 01-15, Volume: 317

    Topics: Adrenergic Agents; Adrenergic Uptake Inhibitors; Animals; Antiparkinson Agents; Bromocriptine; Conditioning, Operant; Desipramine; Excitatory Amino Acid Antagonists; Exploratory Behavior; Gene Expression Regulation; Male; Maze Learning; Nucleus Accumbens; Oxidopamine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Reinforcement, Psychology; Thiazoles; Ventral Tegmental Area

2017